Benzodiazepine Challenge vs. ECT for Catatonia
A young woman in catatonic stupor is beginning to show autonomic instability. The standard benzodiazepine challenge is still first-line, but exactly how long to wait for it to work before escalating to ECT is a real, live disagreement.
I.O., a 23-year-old woman, moved to the city two years ago for a marketing job and had been living with a roommate she met through mutual friends, someone who has stayed at the hospital since bringing her in and who describes I.O. as normally talkative and social, which made the sudden two-day silence alarming enough to act on immediately. I.O. has a known history of schizophrenia and was brought to the emergency department by her roommate after two days of near-total mutism, waxy flexibility on exam, and refusal to eat or drink, consistent with catatonia, confirmed with a BFCRS score in the severe range.
A lorazepam challenge was given on admission with partial improvement in her mutism over the following hours, though she remains largely immobile, and by this morning — roughly eighteen hours into her admission — her vital signs show new low-grade fever and mild tachycardia without an identified infectious source. Her roommate, still at bedside, has been the only source of collateral history available so far, since I.O.'s family lives out of state and is still in transit.
The standard approach to catatonia is a benzodiazepine challenge first, with response guiding next steps, and I.O.'s partial response to lorazepam is a genuinely encouraging sign that argues for continuing and escalating that same approach. The new autonomic changes complicate the picture directly, though: they are early, nonspecific signs that can precede a shift toward malignant catatonia, a life-threatening variant where waiting for further benzodiazepine escalation carries real risk if the picture is actually evolving in that direction. ECT is the definitive, most rapidly effective treatment for catatonia when benzodiazepines aren't sufficient, but committing to it this early, on a partial responder with nonspecific vital sign changes rather than confirmed malignant catatonia, is a real judgment call rather than a protocol-driven next step.
Continue benzodiazepine escalation, or move to ECT now
I'd escalate the lorazepam dose further before committing to ECT. She had a real partial response, and published response rates for a benzodiazepine challenge in catatonia run high — that's a meaningfully positive sign, and the vital sign changes are nonspecific enough right now that I don't want to jump to a more invasive treatment on that basis alone.
You called the vital sign changes nonspecific, and technically they are — but I'd weigh what they're nonspecific FOR more heavily. Fever and tachycardia without a source, appearing on top of catatonia, are the described early pattern for a shift toward malignant catatonia, which Fricchione's original 1997 description of the syndrome, still the figure cited across the literature, put at a mortality rate around fifty percent if it isn't treated aggressively once established. It's also specifically associated with a worse response to benzodiazepines than uncomplicated catatonia — so the treatment we're escalating may become less effective the longer these signs go unaddressed, not just riskier to wait on. I don't think "nonspecific" should mean "wait and see" here.
I don't think either of you is wrong, and I don't think we have to pick between "her response is real" and "the mortality stakes are real" right now. I'd propose a middle path: continue escalating lorazepam over the next several hours with genuinely close vital-sign and neurologic monitoring, but set an explicit, short trigger — any further autonomic worsening, not just persistence — that moves us to urgent ECT immediately. ECT's own response rate in exactly this setting, including in patients who haven't fully responded to benzodiazepines, is strong and well documented. The real danger isn't trialing lorazepam a bit longer under close watch — it's losing time to a delayed decision if the picture actually turns, which a pre-agreed trigger protects against without either of us having to be right in advance.
Agreed: escalate lorazepam now with continuous vital-sign monitoring and a defined four-hour reassessment, and an explicit trigger for immediate ECT consultation if any further autonomic instability develops, not only if the current findings persist unchanged.
Not fully resolved: the critical care physician would have moved to arrange ECT consultation immediately regardless of the plan above, given how quickly malignant catatonia can become difficult to manage once established — a disagreement the team left on record rather than papering over.